ethyl 4-isothiocyanatobutanoate: a potential anti-cancer drug; induces an immediate dose-dependent inhibitory action on the division of HeLa cells [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 123372 |
| SCHEMBL ID | 3083780 |
| MeSH ID | M0220567 |
| Synonym |
|---|
| 17126-65-7 |
| 4-isothiocyanatobutanoic acid ethyl ester |
| butanoic acid, 4-isothiocyanato-, ethyl ester |
| e-4ib |
| ethyl 4-isothiocyanatobutanoate |
| ethyl 4-isothiocyanatobutyrate |
| AKOS006344450 |
| FT-0682042 |
| e-4ib cpd |
| ethyl-4-isothiocyanatobutanoate |
| SCHEMBL3083780 |
| 4-isothiocyanato-butyric acid ethyl ester |
| butyric acid, 4-isothiocyanato-, ethyl ester |
| DTXSID10169051 |
| butanoic acid,4-isothiocyanato-,ethyl ester |
| mfcd00041135 |
| J-010706 |
| EN300-1458804 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.54) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||